Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 36.08 and traded as low as GBX 32.05. Cambridge Cognition shares last traded at GBX 32.05, with a volume of 60,992 shares trading hands.
Cambridge Cognition Stock Performance
The stock has a 50-day simple moving average of GBX 34.02 and a 200 day simple moving average of GBX 36.11. The company has a debt-to-equity ratio of 29.16, a current ratio of 0.40 and a quick ratio of 0.96. The company has a market capitalization of £18.32 million, a PE ratio of -8.71 and a beta of 0.81.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Featured Stories
- Five stocks we like better than Cambridge Cognition
- Datadog’s Drop Says More About Expectations Than Earnings
- D-Wave’s Quantum Breakthrough Couldn’t Save QBTS From a Sell-Off
- Cloudflare’s Beat-and-Raise Quarter Puts Its AI Edge Story in Focus
- Solventum Nears Inflection Point As It Begins to Unlock Value
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
